Free Trial

Aquestive Therapeutics (AQST) Earnings Date, Estimates & Call Transcripts

$3.19
+0.08 (+2.57%)
(As of 05/20/2024 ET)

Earnings Summary

Upcoming
Earnings Date
Aug. 5Estimated
Actual EPS
(May. 13)
-$0.17 Missed By -$0.08
Consensus EPS
(May. 13)
-$0.09
Skip Charts & View Estimated and Actual Earnings Data

AQST Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

AQST Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Aquestive Therapeutics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20242($0.09)($0.04)($0.07) 
Q2 20242($0.08)($0.08)($0.08) 
Q3 20242($0.07)($0.05)($0.06) 
Q4 20242($0.08)($0.04)($0.06) 
FY 20248($0.32)($0.21)($0.27) 
Q1 20251($0.07)($0.07)($0.07) 
Q2 20251($0.08)($0.08)($0.08) 
Q3 20251($0.08)($0.08)($0.08) 
Q4 20251($0.08)($0.08)($0.08) 
FY 20254($0.31)($0.31) ($0.31)

AQST Earnings Date and Information

Aquestive Therapeutics last posted its earnings results on May 13th, 2024. The reported ($0.17) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.09) by $0.08. The company had revenue of $12.05 million for the quarter, compared to analyst estimates of $12.22 million. Aquestive Therapeutics has generated ($0.42) earnings per share over the last year (($0.42) diluted earnings per share). Earnings for Aquestive Therapeutics are expected to grow in the coming year, from ($0.42) to ($0.36) per share. Aquestive Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, August 5th, 2024 based off prior year's report dates.

Aquestive Therapeutics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
8/5/2024
Estimated)
------- 
5/13/2024Q1 2024($0.09)($0.17)($0.08)($0.17)$12.22 million$12.05 million    
3/5/2024Q4 2023($0.08)($0.12)($0.04)($0.12)$11.79 million$13.21 million
11/6/2023Q3 2023($0.11)($0.03)+$0.08($0.03)$11.33 million$13.00 million
8/7/2023Q2 2023($0.11)($0.10)+$0.01($0.10)$10.76 million$13.24 million
5/2/2023Q1 2023($0.10)$0.11+$0.21$0.11$10.17 million$11.13 million
3/8/2023Q4 2022($0.21)($0.23)($0.02)($0.23)$9.93 million$10.68 million    
11/1/2022Q3 2022($0.30)($0.23)+$0.07($0.23)$10.68 million$11.46 million
8/2/2022Q2 2022($0.41)($0.36)+$0.05($0.36)$10.02 million$13.27 million    
5/3/2022Q1 2022($0.45)($0.32)+$0.13($0.32)$9.80 million$12.27 million    
3/8/2022Q4 2021($0.37)($0.38)($0.01)($0.04)$9.81 million$11.08 million    
11/2/2021Q3 2021($0.45)($0.37)+$0.08($0.37)$12.03 million$13.29 million    
8/2/2021Q2 2021($0.44)($0.33)+$0.11($0.33)$10.63 million$15.35 million    

Aquestive Therapeutics Earnings - Frequently Asked Questions

When is Aquestive Therapeutics's earnings date?

Aquestive Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, August 5th, 2024 based off last year's report dates. Learn more on AQST's earnings history.

Did Aquestive Therapeutics beat their earnings estimates last quarter?

In the previous quarter, Aquestive Therapeutics (NASDAQ:AQST) missed the analysts' consensus estimate of ($0.09) by $0.08 with a reported earnings per share (EPS) of ($0.17). Learn more on analysts' earnings estimate vs. AQST's actual earnings.

How can I listen to Aquestive Therapeutics's earnings conference call?

The conference call for Aquestive Therapeutics's latest earnings report can be listened to online. Listen to Conference Call

How can I read Aquestive Therapeutics's conference call transcript?

The conference call transcript for Aquestive Therapeutics's latest earnings report can be read online. Read Transcript

How much revenue does Aquestive Therapeutics generate each year?

Aquestive Therapeutics (NASDAQ:AQST) has a recorded annual revenue of $50.58 million.

How much profit does Aquestive Therapeutics generate each year?

Aquestive Therapeutics (NASDAQ:AQST) has a recorded net income of -$7.87 million. AQST has generated -$0.42 earnings per share over the last four quarters.

What is Aquestive Therapeutics's EPS forecast for next year?

Aquestive Therapeutics's earnings are expected to grow from ($0.42) per share to ($0.36) per share in the next year.


More Earnings Resources from MarketBeat

This page (NASDAQ:AQST) was last updated on 5/21/2024 by MarketBeat.com Staff

From Our Partners